DANA CARNS
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CHANDLER, TX NPI 1033865852
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family TX Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$1,848.04
- Category: General Payments
- Program years: PY2022–2024
- Record count: 73
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,238.73 across 56 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,238.73 | 56 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $231.40 | 10 |
| Lilly USA, LLC | $177.97 | 11 |
| PFIZER INC. | $153.96 | 7 |
| Axsome Therapeutics, Inc. | $120.44 | 1 |
| Novo Nordisk AS | $117.53 | 7 |
| Astellas Pharma US Inc | $105.48 | 1 |
| ABBVIE INC. | $85.28 | 4 |
| Acerta Pharma LLC | $56.62 | 3 |
| Antares Pharma, Inc. | $44.90 | 3 |
| Exact Sciences Corporation | $30.86 | 2 |
| GlaxoSmithKline, LLC. | $29.21 | 2 |
| Biogen, Inc. | $22.12 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.55 | 1 |
| Paratek Pharmaceuticals, Inc. | $14.80 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.25 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $13.36 | 1 |
By program year
Records — PY2024 (56)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.